Literature DB >> 8627734

Defined large-scale alterations of the human cytomegalovirus genome constructed by cotransfection of overlapping cosmids.

G Kemble1, G Duke, R Winter, R Spaete.   

Abstract

We have constructed defined human cytomegalovirus (CMV) mutants by cotransfecting overlapping cosmid clones spanning the 230-kbp genome. Using this strategy, we have introduced a 13-kbp region of DNA from a virulent strain of CMV into a defined position within the avirulent CMV(Towne) genome. Although more than 80% of the genome of these recombinant viruses was derived from Towne DNA, their plaque morphology more closely resembled that of Toledo. To date, CMV is the largest virus and requires the greatest number of cosmids to be regenerated via overlapping cosmid cotransfection.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8627734      PMCID: PMC190037     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  17 in total

1.  Identification of the lytic origin of DNA replication in human cytomegalovirus by a novel approach utilizing ganciclovir-induced chain termination.

Authors:  F M Hamzeh; P S Lietman; W Gibson; G S Hayward
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

Review 2.  Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169.

Authors:  M S Chee; A T Bankier; S Beck; R Bohni; C M Brown; R Cerny; T Horsnell; C A Hutchison; T Kouzarides; J A Martignetti
Journal:  Curr Top Microbiol Immunol       Date:  1990       Impact factor: 4.291

3.  A cytomegalovirus protein with properties of herpes simplex virus ICP8: partial purification of the polypeptide and map position of the gene.

Authors:  G W Kemble; A L McCormick; L Pereira; E S Mocarski
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

4.  Insertion and deletion mutagenesis of the human cytomegalovirus genome.

Authors:  R R Spaete; E S Mocarski
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

5.  Comparative virulence and immunogenicity of the Towne strain and a nonattenuated strain of cytomegalovirus.

Authors:  G V Quinnan; M Delery; A H Rook; W R Frederick; J S Epstein; J F Manischewitz; L Jackson; K M Ramsey; K Mittal; S A Plotkin
Journal:  Ann Intern Med       Date:  1984-10       Impact factor: 25.391

6.  Regeneration of herpesviruses from molecularly cloned subgenomic fragments.

Authors:  M van Zijl; W Quint; J Briaire; T de Rover; A Gielkens; A Berns
Journal:  J Virol       Date:  1988-06       Impact factor: 5.103

7.  A host cell protein binds to a highly conserved sequence element (pac-2) within the cytomegalovirus a sequence.

Authors:  G W Kemble; E S Mocarski
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

8.  Replacement mutagenesis of the human cytomegalovirus genome: US10 and US11 gene products are nonessential.

Authors:  T R Jones; V P Muzithras; Y Gluzman
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

9.  Human cytomegalovirus origin of DNA replication (oriLyt) resides within a highly complex repetitive region.

Authors:  M J Masse; S Karlin; G A Schachtel; E S Mocarski
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

10.  Boundaries and structure of human cytomegalovirus oriLyt, a complex origin for lytic-phase DNA replication.

Authors:  D G Anders; M A Kacica; G Pari; S M Punturieri
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

View more
  45 in total

1.  Systematic excision of vector sequences from the BAC-cloned herpesvirus genome during virus reconstitution.

Authors:  M Wagner; S Jonjic; U H Koszinowski; M Messerle
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

2.  A nine-codon deletion mutation in the cytomegalovirus UL97 phosphotransferase gene confers resistance to ganciclovir.

Authors:  S Chou; C L Meichsner
Journal:  Antimicrob Agents Chemother       Date:  2000-01       Impact factor: 5.191

3.  Abundant early expression of gpUL4 from a human cytomegalovirus mutant lacking a repressive upstream open reading frame.

Authors:  J P Alderete; S J Child; A P Geballe
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

4.  Human cytomegalovirus latency-associated protein pORF94 is dispensable for productive and latent infection.

Authors:  K L White; B Slobedman; E S Mocarski
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

5.  Construction of varicella-zoster virus recombinants from parent Oka cosmids and demonstration that ORF65 protein is dispensable for infection of human skin and T cells in the SCID-hu mouse model.

Authors:  Takahiro Niizuma; Leigh Zerboni; Marvin H Sommer; Hideki Ito; Stewart Hinchliffe; Ann M Arvin
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

6.  Development and preclinical evaluation of an alphavirus replicon particle vaccine for cytomegalovirus.

Authors:  Elizabeth A Reap; John Morris; Sergey A Dryga; Maureen Maughan; Todd Talarico; Robert E Esch; Sarah Negri; Bruce Burnett; Andrew Graham; Robert A Olmsted; Jeffrey D Chulay
Journal:  Vaccine       Date:  2007-08-30       Impact factor: 3.641

7.  A genetic system for rhesus monkey rhadinovirus: use of recombinant virus to quantitate antibody-mediated neutralization.

Authors:  John P Bilello; Jennifer S Morgan; Blossom Damania; Sabine M Lang; Ronald C Desrosiers
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

Review 8.  RNA virus vectors: where are we and where do we need to go?

Authors:  P Palese
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-27       Impact factor: 11.205

9.  A Phase 1 Study of 4 Live, Recombinant Human Cytomegalovirus Towne/Toledo Chimera Vaccines in Cytomegalovirus-Seronegative Men.

Authors:  Stuart P Adler; Anne-Marie Manganello; Ronzo Lee; Michael A McVoy; Daniel E Nixon; Stanley Plotkin; Edward Mocarski; Josephine H Cox; Patricia E Fast; Pavlo A Nesterenko; Susan E Murray; Ann B Hill; George Kemble
Journal:  J Infect Dis       Date:  2016-08-11       Impact factor: 5.226

10.  Characterization of drug resistance-associated mutations in the human cytomegalovirus DNA polymerase gene by using recombinant mutant viruses generated from overlapping DNA fragments.

Authors:  T Cihlar; M D Fuller; J M Cherrington
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.